INVESTORS / PUFFIDO
P / 05A new breath.A new opportunity.
A reusable platform, a B2B model and a development programme for inhalation therapy. The planned first round funds pDPI validation.
ExploreFunctional prototype · Technology in development
01 / MARKET OPPORTUNITY
The scale
of the opportunity.
€5B+
Global market
€1B
Europe
€145M
Italy
Market sizes reported in the project poster.
02 / B2B BUSINESS MODEL
The device stays.
The relationship continues.
Customised devices and refills distributed through pharmaceutical partners. A B2B model connecting the technology platform to different formulations and industrial pathways.
Poster financial assumptions
The poster states revenue above €3 million and 25% EBITDA, assuming a 12.5% share of the Italian market. These are project forecasts, not operating results.
03 / DEVELOPMENT ROADMAP
Four milestones.
One defined path.
€3M
Planned first round
2026
pDPI validation
€3M2027
Clinical preparation
€2.8M2028
pDPI market entry
€2.2M2029
Liquid inhaler extension
€8M€8 million for the powder programme + €8 million for the liquid extension. Dates are development plan targets.
Download the project poster04 / THE INVESTMENT PERSPECTIVE
Intellectual property
Validation before market entry
RESEARCH. INDUSTRY. NEW POSSIBILITIES.
The future is built
together.
Let’s open a conversation about the future of inhalation therapy.
Contact the team